News | October 30, 2022
Kopran acquire assets of Abhinandan Rasayan
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
The observation is procedural in nature and the company will address the observation within stipulated timelines.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
Results reinforce commitment to next-generation oral SERD development programme
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
Subscribe To Our Newsletter & Stay Updated
